The release of HMGB1 from necroptotic tumor cells that underwent ablative HFRT suggests that necroptosis induced by ablative HFRT is immunogenic and has the potential to activate immune response although there is very little direct evidence available about it. This evidence concerns the gene HMGB1 and neoplasm.